MASSACHUSETTS GENERAL HOSPITAL
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
The Monitoring Study
Not Applicable
Completed
- Conditions
- Type1diabetes
- Interventions
- Other: Monitored for HypoglycemiaOther: Not Monitored for HypoglycemiaDevice: Bihormonal Bionic PancreasDevice: Insulin Only Bionic Pancreas
- First Posted Date
- 2016-11-21
- Last Posted Date
- 2018-07-30
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 27
- Registration Number
- NCT02969863
- Locations
- πΊπΈ
MGH Diabetes Research Center, Boston, Massachusetts, United States
Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine
Phase 4
Terminated
- Conditions
- Depressive DisorderMajor DepressionDepressionDepression, Unipolar
- Interventions
- First Posted Date
- 2016-11-21
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT02969876
- Locations
- πΊπΈ
the Massachusetts General Hospital, Boston, Massachusetts, United States
Post Bariatric Closed Loop Glucagon Trial
Not Applicable
Completed
- Conditions
- Hypoglycemia
- Interventions
- Device: Glucagon-only bionic pancreas - placeboDevice: Glucagon-only bionic pancreas - glucagon
- First Posted Date
- 2016-11-17
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02966275
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: A Treatment Development and Pilot Study
Not Applicable
Completed
- Conditions
- Avoidant/Restrictive Food Intake Disorder (ARFID)
- Interventions
- Behavioral: CBT-AR
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT02963220
- Locations
- πΊπΈ
Eating Disorders Clinical and Research Program (Massachusetts General Hospital), Boston, Massachusetts, United States
Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 198
- Registration Number
- NCT02961946
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT02959996
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
An Engagement Engine for Fitness Trackers
Not Applicable
Completed
- Conditions
- ObeseOverweight
- Interventions
- Other: Machine Learning Algorithm
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 184
- Registration Number
- NCT02960386
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)
Not Applicable
Completed
- Conditions
- DepressionMajor Depressive Disorder
- Interventions
- Device: Transcranial Light TherapyDevice: Sham Transcranial Light Therapy
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT02959307
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
πΊπΈNathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
Phase 4
Withdrawn
- Conditions
- Acute PainPain, PostoperativeFacial Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-11-06
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT02957097
- Locations
- πΊπΈ
Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States
Administration of Kisspeptin in Patients With Hyperprolactinemia
Phase 2
Completed
- Conditions
- HypogonadismHyperprolactinemia
- Interventions
- First Posted Date
- 2016-11-06
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT02956447
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States